November 16, 2026

What a Med Spa Should Actually Spend Per New Patient

Cost per lead hides the truth. Here is how to calculate what a new med spa patient is worth in 12 months and what you can afford to pay to acquire one.

What a Med Spa Should Actually Spend Per New Patient

There is no single number, and anyone who hands you one has skipped the only calculation that matters. What you can afford to spend on a new patient is a function of what that patient is worth to you over twelve months, how fast the first visit pays back the spend, and whether your booking path converts the interest you buy. Most practices can afford considerably more than they are currently bidding, which is precisely why they keep losing the patients they most want.

Here is the math, the payback logic, and the one page scorecard that replaces cost per lead for good.

Why your cost per lead tells you almost nothing

A fourteen dollar lead sounds like a win until you ask what that lead walked in for. Fourteen dollars for a patient whose entry point is a two hundred dollar facial is a different business from fourteen dollars for a patient entering on a device package. Same ad account, same dashboard, same satisfying downward trend in the cost per lead column. Completely different outcomes on your P&L.

Cost per lead measures the price of a form fill. It does not measure whether the phone was answered, whether the consult was booked, whether the patient showed, what they bought, or whether they came back. In aesthetics, where entry treatments range from a single tox appointment to a multi thousand dollar device plan, optimising cost per lead means optimising for the cheapest possible interest, which is usually the least valuable interest.

The number that decides whether marketing is working is cost per acquired patient, measured against twelve month patient value by entry treatment. Two inputs. Everything else is reporting decoration.

What one new patient is actually worth in twelve months

Start with the industry baseline, then correct it to your own practice.

The American Med Spa Association's 2024 State of the Industry work found that patients spend an average of 527 dollars during a medical spa visit, roughly in line with the 536 dollar figure in its 2022 report, which AmSpa notes was likely inflated by the post lockdown rush. The same research put the average medical spa at 245 patient visits per month, almost exactly where it sat in 2018. And the number that should change how you budget: an average of 73 percent of medical spa patients are repeat patients, up from 65 percent in the 2022 report.

Run the arithmetic. Take one new patient. If they return on a normal tox cadence, call it three visits across the year, and each visit tracks near that 527 dollar average, you are looking at roughly 1,581 dollars of year one value before a single device consult, skincare order or filler cycle is added.

That is a model, not a promise. But it is the model that reframes the conversation. An owner who says 250 dollars is too expensive for a new patient is measuring that number against one transaction. Against 1,581 dollars of first year value, 250 dollars is not expensive. It is cheap, and the practice refusing to pay it is handing those patients to someone who will.

Two corrections before you use any of this.

Strip out non medical services. AmSpa's 2022 executive summary reported 283 non-surgical aesthetic patient visits per month, excluding other services such as massage, nails, hair and yoga, against 245 patient visits per month in the 2024 report. If your average visit value is propped up by services with different margins and different repeat behaviour, your acquisition math inherits that distortion. Our view: calculate entry point value on the treatments your ads actually promote, not on a blended figure that includes services you are not advertising.

Segment by entry treatment, not in aggregate. A blended patient value is an average of businesses you run differently. Build the number four or five times:

  • Tox and filler entry: visit value times realistic annual cadence, plus the percentage who add skincare.
  • Facial or membership entry: lower first visit, often higher visit frequency, and the question is what percentage convert to injectables within the year.
  • Device entry: high first transaction, longer gap to the next, strong candidate for package pricing.
  • Consultation entry for surgical or high ticket work: low volume, long consideration, and a value that can justify acquisition costs that would look insane on a facial.

Twelve month value is not a number you inherit. It is a number you build. The gap between a patient who books once and a patient who books three times is usually reactivation machinery, not clinical skill: automated email sequences that bring patients back on cadence, SMS reactivation for the patients who drifted at month seven, and an AI receptionist catching the calls that currently ring out during treatment hours. Every one of those lifts the ceiling on what you can afford to bid.

How fast does the first visit need to pay back the spend?

This is where cash pay practices quietly disadvantage themselves. There is no insurance lag, no claims process, no collections risk. The money arrives at the front desk. That means you can run a longer payback window than most owners permit themselves.

Pick your window deliberately:

  • First visit payback. Acquisition cost must be covered by the first transaction. Safest, slowest growth, and it will price you out of your best patients.
  • Ninety day payback. Acquisition is covered by the first two visits. A reasonable default for an established practice with a working recall system.
  • Twelve month payback. Acquisition is covered by the year one value. Appropriate when your repeat rate is proven, your retention systems are running, and you have the cash position to float the gap.

The constraint is not accounting. It is cash flow and retention confidence. If you cannot evidence your repeat rate from your own records, do not run a twelve month window on faith. Run ninety days, measure the cohort, extend when the data supports it.

And one hard precondition. Do not lengthen your payback window to buy more traffic into a leaking funnel. If calls go unanswered, if the site takes four clicks to reach a booking, if consults are booked but not confirmed, a longer window simply buys more expensive leakage. Fix the path first. That is why an audit comes before a budget conversation every time.

Why underbidding quietly hands your best patients to a weaker practice

Paid auctions do not reward clinical excellence. They reward willingness to pay.

When you cap your bid based on a single transaction while a competitor caps theirs based on twelve month value, they outbid you on the highest intent searches in your area. Not occasionally. Structurally. You stop appearing to the patients worth the most, and the better funded practice acquires them regardless of who is better in the room.

The pressure is increasing. AmSpa reported that 18 percent of medical spas were newly opened in 2023, a slight increase from 17 percent in the 2022 report, and and AmSpa's medical spa statistics page puts the medical aesthetics industry at more than 17 billion dollars, growing by more than a billion a year. More practices, more bidders, more competition for the same high intent queries. The owners who have done the twelve month math will keep winning those auctions. The ones optimising cost per lead will keep congratulating themselves on cheap traffic that never fills a calendar.

The three numbers on your one page monthly scorecard

Delete the rest. Report these every month:

  1. Acquired patients. Not leads, not clicks, not form fills. Patients who attended and paid, counted by entry treatment.
  2. Blended acquisition cost. Total marketing spend divided by acquired patients. Everything in the numerator: ads, content, production, agency fees. Flattering numbers come from partial numerators.
  3. Twelve month value by entry treatment. Tracked as cohorts. January's new patients, what they have spent by June, by December.

Three numbers, one page, reviewed monthly. When blended acquisition cost sits well under twelve month value and your payback window is holding, the correct response is to spend more, not to congratulate yourself on efficiency.

If you are opening and have no history yet

You model it, then you replace the model.

Take your planned treatment mix, your own pricing, and published visit averages. Assume a conservative repeat rate below the 73 percent of patients who are repeat patients industry-wide, because a new practice has no recall list and no reactivation history. That gives you a defensible opening ceiling for acquisition cost. Then replace every assumption with real cohort data by month four. Your first hundred patients will tell you more about your economics than any benchmark ever will.

Until then, bid to the model, keep the payback window short, and watch the booked consult rate rather than the lead count.

If you want this run on your actual numbers, that is what our free 15 minute discovery call is for. We will look at your entry treatments, your repeat behaviour and where patients are slipping out of your booking path, and tell you what you can genuinely afford to spend. No commitment, just the math.

Frequently asked questions

How much should a med spa spend to acquire a new patient?

There is no single correct number, because it depends on your entry treatment and your repeat rate. Build it from twelve month patient value: at the industry average of 527 dollars per visit and a normal tox cadence of three visits in a year, a patient can be worth roughly 1,581 dollars in year one before cross sell. Against that figure, acquisition costs many owners consider expensive are comfortably affordable.

Why is cost per lead a bad metric for aesthetic practices?

Cost per lead measures the price of a form fill, not whether the patient booked, attended, paid or returned. A cheap lead for a low value facial and the same priced lead for a device patient are completely different businesses. Optimising cost per lead usually means optimising for the cheapest interest, which is often the least valuable.

How long should it take for a new patient to pay back my ad spend?

Choose between first visit, ninety day or twelve month payback based on your cash position and how confident you are in your repeat rate. Cash pay practices have no insurance lag or collections risk, so they can usually carry a longer window than they allow themselves. If you cannot evidence your repeat rate from your own records, run ninety days first and extend once cohort data supports it.

What should I track if I just opened and have no patient history?

Model your acquisition ceiling from your planned treatment mix, your own pricing and published visit averages, using a repeat rate below the 73 percent of patients who are repeat patients industry-wide, because you have no recall list yet. Keep the payback window short and watch booked consult rate rather than lead count. Replace every assumption with real cohort data by month four.

Should I increase my ad budget if my acquisition cost looks good?

Only after you have confirmed the booking path converts. Raising spend into a funnel where calls go unanswered or booking takes too many clicks simply buys more expensive leakage. Audit visibility and the booking path first, then scale.

Ready When You Are

Ready to Grow Your Practice?

Let's build a marketing system that attracts the right patients and keeps them coming back. Start with a free 15-minute call.

Book a Discovery Call →

Free. No commitment. Just strategy.

Emma